Identification takes just minutes, potentially saving weeks of waiting to get a tumor analyzed.

New approaches and insights help Dr. Bashar A. Safar and his collaborators achieve stellar results.

Experiments showed that the antibacterial biologic agent was superior to a standard antibiotic drug.

The combination reduced melanoma recurring or causing death by 44 percent compared with immunotherapy alone.

Using AI on a huge database of brain tumor images helps clinicians assess responses to treatment.

The drug, mirvetuximab soravtansine, is potentially a highly specific therapeutic drug.

Dr. Alec Kimmelman has made critical discoveries that could lead to new pancreatic cancer drugs.

Dr. Mohammad Maher Abdul Hay says treatment advances and clinical trial availability offer people new hope.

Antibody–drug conjugates can deliver tumor-killing drugs with higher specificity and less toxicity.

The research team joins four other multidisciplinary teams around the country.